Coeptis Therapeutics, Inc.

General ticker "COEP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $131.2M (TTM average)

Coeptis Therapeutics, Inc. follows the US Stock Market performance with the rate: 41.0%.

Estimated limits based on current volatility of 4.3%: low 13.27$, high 14.47$

Factors to consider:

  • Total employees count: 5 (0.0%) as of 2022
  • Current price 30.1% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.31$, 13.90$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.87$, 9.74$]

Financial Metrics affecting the COEP estimates:

  • Positive: with PPE of -8.2 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -34.45 <= 0.04
  • Positive: 19.35 < Shareholder equity ratio, % of 35.75 <= 42.53
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 2.05 <= 3.31

Similar symbols

Short-term COEP quotes

Long-term COEP plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM
Operating Expenses $21.49MM $10.05MM
Operating Income $-21.49MM $-10.05MM
Non-Operating Income $0.22MM $-0.82MM
Interest Expense $0.11MM $0.40MM
R&D Expense $6.67MM $2.33MM
Income(Loss) $-21.27MM $-10.88MM
Profit(Loss)* $-21.27MM $-10.88MM
Stockholders Equity $4.31MM $3.19MM
Assets $8.07MM $8.91MM
Operating Cash Flow $-7.24MM $-6.65MM
Financing Cash Flow $4.92MM $5.71MM
Earnings Per Share** $-0.83 $-5.65

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.